CA Stock MarketDetailed Quotes
FRX Fennec Pharmaceuticals Inc
- 8.930
- +0.020+0.22%
15min DelayMarket Closed Dec 24 13:00 ET
244.97MMarket Cap-165.37P/E (TTM)
8.930High8.930Low100Volume8.930Open8.910Pre Close893.00Turnover15.20052wk High0.00%Turnover Ratio27.43MShares5.65052wk Low-0.054EPS TTM167.96MFloat Cap391.500Historical HighLossP/E (Static)18.81MShs Float0.270Historical Low-0.795EPS LYR0.00%Amplitude--Dividend TTM-32.95P/B1Lot Size--Div YieldTTM
Fennec Pharmaceuticals Inc Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 20.07%-2.21M | -112.54%-8.39M | 800.14%39.05M | 5.07%-17.14M | 28.55%-4.86M | 44.91%-2.76M | -16.40%-3.95M | -95.27%-5.58M | -26.97%-18.06M | -109.61%-6.8M |
| Net income from continuing operations | -207.18%-5.74M | -2.00%-5.55M | 312.11%12.84M | 32.34%-16.05M | 60.89%-2.68M | 76.92%-1.87M | -7.33%-5.44M | -63.74%-6.05M | -36.71%-23.71M | -54.89%-6.86M |
| Depreciation and amortization | --25K | 150.00%26K | 1,290.38%723K | ---- | ---- | --0 | ---52K | --52K | ---- | ---- |
| Unrealized gains and losses of investment securities | ---- | ---11K | -63.33%11K | -78.80%39K | ---- | ---- | --0 | -67.03%30K | 636.00%184K | -64.20%58K |
| Remuneration paid in stock | 110.52%1.82M | -63.63%925K | 9.37%1.19M | 31.00%5.35M | 3.63%857K | -53.32%865K | 152.28%2.54M | 172.93%1.09M | 9.02%4.09M | -10.01%827K |
| Other non cashItems | -57.58%336K | 242.40%428K | 1,990.00%418K | 1.77%287K | -750.00%-650K | 708.16%792K | 190.70%125K | -51.22%20K | 0.00%282K | -62.26%100K |
| Change In working capital | -9.64%-2.76M | -276.83%-4.21M | 3,433.38%23.87M | -714.51%-6.78M | -160.65%-2.42M | -328.88%-2.52M | -279.45%-1.12M | -331.72%-716K | 218.35%1.1M | -467.07%-930K |
| -Change in receivables | -101.92%-4.2M | -167.45%-2.04M | -957.97%-1.46M | -370.49%-7.27M | -177.61%-4.29M | ---2.08M | ---762K | ---138K | ---1.55M | ---1.55M |
| -Change in inventory | 258.86%502K | 84.64%-80K | 126.90%92K | -174.31%-1.58M | 30.38%-401K | ---316K | ---521K | ---342K | ---576K | ---576K |
| -Change in prepaid assets | 525.24%1.31M | -40.11%109K | -1,560.31%-1.91M | -60.61%104K | 14.84%-419K | -0.94%210K | -19.11%182K | -58.93%131K | 211.39%264K | -348.48%-492K |
| -Change in payables and accrued expense | 8.68%-305K | -12,147.06%-2.08M | 654.50%2.04M | -33.51%1.96M | 59.55%2.68M | -137.53%-334K | -104.24%-17K | -1,938.89%-367K | 526.26%2.95M | 566.94%1.68M |
| -Change in other current assets | --364K | ---122K | ---133K | -50.00%3K | 50.00%3K | --0 | --0 | --0 | 400.00%6K | 200.00%2K |
| -Change in other current liabilities | ---437K | --0 | --25.25M | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 20.07%-2.21M | -112.54%-8.39M | 800.14%39.05M | 5.07%-17.14M | 28.55%-4.86M | 44.91%-2.76M | -16.40%-3.95M | -95.27%-5.58M | -26.97%-18.06M | -109.61%-6.8M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | ||||||||||
| Cash from discontinued investing activities | ||||||||||
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -362.69%-528K | -50.00%257K | -686.53%-1.13M | -67.98%6.64M | 595.39%5.73M | -98.99%201K | 1,017.39%514K | 1,186.67%193K | 316.47%20.73M | 8,140.00%824K |
| Net issuance payments of debt | ---- | ---- | ---- | -74.93%5M | ---- | ---- | ---- | ---- | 298.70%19.94M | ---65K |
| Proceeds from stock option exercised by employees | -318.60%-470K | -35.86%347K | 194.37%627K | 84.91%1.72M | 10.01%747K | 14.36%215K | 1,076.09%541K | 1,320.00%213K | 2,712.12%928K | 7,444.44%679K |
| Net other financing activities | -314.29%-58K | -233.33%-90K | -8,695.00%-1.76M | 42.75%-75K | -106.67%-14K | ---14K | ---27K | ---20K | -138.18%-131K | 20,900.00%210K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -362.69%-528K | -50.00%257K | -686.53%-1.13M | -67.98%6.64M | 595.39%5.73M | -98.99%201K | 1,017.39%514K | 1,186.67%193K | 316.47%20.73M | 8,140.00%824K |
| Net cash flow | ||||||||||
| Beginning cash position | 187.83%43.05M | 178.33%51.18M | -44.19%13.27M | 12.67%23.77M | -58.33%12.4M | 0.29%14.96M | 0.72%18.39M | 12.67%23.77M | -30.46%21.1M | 22.26%29.75M |
| Current changes in cash | -6.84%-2.73M | -136.89%-8.13M | 804.22%37.92M | -492.86%-10.51M | 114.55%870K | -117.25%-2.56M | -2.63%-3.43M | -89.51%-5.38M | 128.93%2.67M | -84.79%-5.98M |
| End cash Position | 225.19%40.32M | 187.83%43.05M | 178.33%51.18M | -44.19%13.27M | -44.19%13.27M | -58.33%12.4M | 0.29%14.96M | 0.72%18.39M | 12.67%23.77M | 12.67%23.77M |
| Free cash from | 20.07%-2.21M | -112.54%-8.39M | 800.14%39.05M | 5.07%-17.14M | 28.55%-4.86M | 44.91%-2.76M | -16.40%-3.95M | -95.27%-5.58M | -26.97%-18.06M | -109.61%-6.8M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Price
% Chg
No Data